Practical Guide to Psychiatric Medications Simple Concise Uptodate

How much time do you spend researching psychiatric medications? How often does a patient ask you a question about a medication to which you don’t know the answer? Have you ever wished that you could find a single reference source for all psychiatric medications instead of sifting through bulky books and websites for quick answers?

Now, thanks to the complete and cutting-edge reference, Practical Guide to Psychiatric Medications, written by award-winning psychiatrist Tanveer A. Padder, MD, you can bring your valuable attention back to your patients. This Updated and revised 2nd edition examines numerous psychiatric disorders including depression, anxiety, psychosis, bipolar, ADHD, substance abuse, PTSD, and others and then provides detailed, evidence-based clinical accounts of effective drug therapies while covering everything from the dosing protocols and side effects to the drug-drug interactions and much more. In addition to discussing certain special populations such as children, the elderly, and pregnant women, this resource also includes other currently relevant drug information like black box warnings, dietary and herbal medications, and future medications.

By presenting all of this essential information on psychotropic medications in an accessible and digestible format, this book will quickly become an invaluable reference for medical and mental health professionals to make efficient and well-informed clinical judgments. Physicians, Nurse Practitioners, Psychologists, Medical students, Interns, Residents, Nurses, and Therapists alike will find this information extremely helpful in achieving clinical excellence while streamlining their daily work routine.

Tanveer A. Padder, MD is an award-winning psychiatrist, master Psycho-pharmacologist, addiction specialist, academician, and clinical researcher. He is certified by the American Board of Psychiatry and Neurology, the American Board of Addiction Medicine and has additional certification by the American Board of Clinical Psycho-pharmacology.